Moleculin Biotech Cash from Financing (TTM) Analysis

Moleculin Biotech Inc (MBRX)

5.05 +0.03 (+0.60%) USD | NASDAQ | May 06, 16:00

5.43 +0.38 (+7.52%) Pre-Market: 08:17

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2016. Upgrade now.

Date	Value
December 31, 2023	4.651M
September 30, 2023	0.186M
June 30, 2023	0.179M
March 31, 2023	0.118M
December 31, 2022	-0.023M
September 30, 2022	-0.023M
June 30, 2022	-0.036M
March 31, 2022	-0.024M
December 31, 2021	74.72M
September 30, 2021	80.21M
June 30, 2021	81.99M
March 31, 2021	92.01M
December 31, 2020	22.55M
September 30, 2020	17.06M
June 30, 2020	15.36M

Date	Value
March 31, 2020	20.62M
December 31, 2019	20.85M
September 30, 2019	22.62M
June 30, 2019	22.56M
March 31, 2019	9.351M
December 31, 2018	12.04M
September 30, 2018	11.67M
June 30, 2018	12.75M
March 31, 2018	13.01M
December 31, 2017	10.06M
September 30, 2017	8.678M
June 30, 2017	7.595M
March 31, 2017	13.58M
December 31, 2016	8.865M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-0.036M

Minimum

Jun 2022

92.01M

Maximum

Mar 2021

25.03M

Average

17.06M

Median

Sep 2020

Cash from Financing (TTM) Benchmarks